Black Friday Savings ! Exclusive Deals on Latest Pharma and Medical Technology Reports.

Explore Now

Fecal Incontinence Epidemiology Forecast

DelveInsight’s ‘Fecal Incontinence–Epidemiology Forecast—2030’ report delivers an in-depth understanding of the Fecal Incontinence, historical and forecasted epidemiology in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Geography Covered

  • The United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan

Study Period: 2018–2030

Fecal Incontinence Disease Understanding

Fecal Incontinence (FI) is the involuntary passage of fecal matter through anus or inability to control the discharge of bowel contents. Its severity can range from an involuntary passage of flatus to complete evacuation of fecal matter. Depending on the severity of the disease, it has a significant impact on a patient’s quality of life. The severity of incontinence can range from unintentional elimination of flatus to the seepage of liquid fecal matter to complete evacuation of the bowel contents. Because of the embarrassment, patients are often reluctant to report fecal incontinence (Shah & Villanueva Herrero, 2021)


Fecal Incontinence is a highly prevalent problem resulting in an inability to control the discharge of bowel contents. Its severity can range from the involuntary passage of flatus to the involuntary evacuation of fecal matter.


There are many etiologies that result in fecal incontinence, and many of them are treatable. A proper history and physical exam and appropriately guided investigations often identify easily correctable causes of fecal incontinence.


There are several nonsurgical and surgical options for the treatment of fecal incontinence. Biofeedback is among the most successful non-operative strategies. Depending on the cause, anal sphincter repair, artificial bowel sphincter, and sacral nerve stimulation are used to treat fecal incontinence with some success.

Unfortunately, fecal incontinence is an extremely difficult problem to manage: there has not been one, single treatment option that has proven to be both safe and effective in long-term studies.

Fecal Incontinence Epidemiology

The Fecal Incontinence epidemiology division provides insights about the historical and current patient pool along with the forecasted trend for every seven major countries. It helps recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken.


Key Findings

The disease epidemiology covered in the report provides historical as well as forecasted Fecal Incontinence epidemiology segmented as the Prevalence of Fecal Incontinence, Prevalence of Fecal Incontinence based on Risk Factors, Gender-specific Prevalence of Fecal Incontinence, Prevalence of Fecal Incontinence based on frequency. The report includes the Prevalent scenario of Fecal Incontinence in 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2018 to 2030.

Country Wise- Fecal Incontinence Epidemiology

The epidemiology segment also provides the Fecal Incontinence epidemiology data and findings across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

  • The total prevalent population of Fecal Incontinence Associated in 7MM countries was estimated to be 11,345,694 cases in 2020 and expected to increase at a CAGR of 0.39% for the study period, i.e., 2018–2030.
  • As per the estimates, United States has the highest prevalent population of Fecal Incontinence in 7MM.
  • Among the EU5 countries, France had the highest prevalent population of Fecal Incontinence. On the other hand, Spain had the lowest number of cases, 508,589 cases in 2020.

Scope of the Report

  • Fecal Incontinence report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis, and treatment patterns
  • Fecal Incontinence Epidemiology Report and Model provide an overview of the risk factors and global trends of Fecal Incontinence in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan)
  • The report provides insight into the historical and forecasted patient pool of Fecal Incontinence in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
  • The report helps recognize the growth opportunities in the 7MM concerning the patient population
  • The report assesses the disease risk and burden and highlights the unmet needs of Fecal Incontinence
  • The report provides the segmentation of the Fecal Incontinence epidemiology by prevalent Cases of Fecal Incontinence in 7MM
  • The report provides the segmentation of the Fecal Incontinence epidemiology by Prevalence of Fecal Incontinence, Prevalence of Fecal Incontinence based on Clinical Manifestation, Gender-specific cases of Fecal Incontinence, Diagnosed cases GCA in Fecal Incontinence in 7MM

Report Highlights

  • 10-year Forecast of Fecal Incontinence epidemiology
  • 7MM Coverage
  • Total Prevalent Cases of Fecal Incontinence
  • Prevalent Cases of Fecal Incontinence based on Risk Factors
  • Gender-specific Prevalence of Fecal Incontinence
  • Prevalence of Fecal Incontinence based on frequency

KOL Views

We interview KOLs, and SME’s opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.

Key Questions Answered

  • What will be the growth opportunities in the 7MM concerning the patient population about Fecal Incontinence?
  • What are the key findings of Fecal Incontinence epidemiology across 7MM, and which country will have the highest number of patients during the forecast period (2021–2030)?
  • What would be the total number of patients with Fecal Incontinence across the 7MM during the forecast period (2021–2030)?
  • Among the EU5 countries, which country will have the highest number of patients during the forecast period (2021–2030)?
  • At what CAGR the patient population is expected to grow by 7MM during the forecast period (2021–2030)?
  • What are the disease risk, burden, and unmet needs of Fecal Incontinence?
  • What are the currently available treatments for Fecal Incontinence?

Reasons to buy

The Fecal Incontinence Epidemiology report will allow the user to -

  • Develop business strategies by understanding the trends shaping and driving the global Fecal Incontinence market
  • Quantify patient populations in the global Fecal Incontinence market to improve product design, pricing, and launch plans
  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Fecal Incontinence therapeutics in each of the markets covered
  • Understand the magnitude of Fecal Incontinence population by its prevalent cases
  • Understand the magnitude of Fecal Incontinence population by its clinical manifestation specific cases
  • The Fecal Incontinence epidemiology report and model was written and developed by Masters and PhD level epidemiologists
  • The Fecal Incontinence Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based on transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over a 10-year forecast period using reputable sources

Key Assessments

  • Patient Segmentation
  • Disease Risk and Burden
  • Risk of disease by the segmentation
  • Factors driving growth in a specific patient population

1. Key Insights

2. Report Introduction

3. Fecal incontinence Market Overview at a Glance

3.1. Market Share (%) Distribution of Fecal incontinence in 2018

3.2. Market Share (%) Distribution of Fecal incontinence in 2030

4. Executive Summary of Fecal Incontinence

5. Disease Background and Overview

5.1. Introduction

5.2. Etiology

5.3. Clinical Manifestations

5.4. Subtypes of Fecal Incontinence

5.5. Pathophysiology

5.6. Diagnosis

6. Management and Treatment

6.1. Guidelines

6.1.1. American Society of Colon and Rectal Surgeons Guidelines

6.1.2. Japan Society of Coloproctology Guidelines

6.1.3. NICE (National Institute for Health & Care Excellence) Society Guidelines

7. Epidemiology and Patient Population

7.1. Key Findings

7.2. 7MM Total Prevalent Patient Population of Fecal incontinence

7.3. Epidemiology of Fecal incontinence

7.4. The United States

7.4.1. Prevalence of Fecal Incontinence in the United States

7.4.2. Prevalent Cases of Fecal Incontinence based on Risk Factors in the United States

7.4.3. Gender-specific Prevalence of Fecal Incontinence in the United States

7.4.4. Prevalence of Fecal Incontinence based on frequency in the United States

7.5. EU5

7.5.1. Germany

7.5.2. France

7.5.3. Italy

7.5.4. Spain

7.5.5. United Kingdom

7.6. Japan

7.6.1. Prevalence of Fecal Incontinence in Japan

7.6.2. Prevalent Cases of Fecal Incontinence based on Risk Factors in Japan

7.6.3. Gender-specific Prevalence of Fecal Incontinence in Japan

7.6.4. Prevalence of Fecal Incontinence based on frequency in Japan

8. Organizations contributing towards Fecal Incontinence

9. Patient Journey

10. Case Reports

11. Appendix

11.1. Bibliography

11.2. Report Methodology

12. DelveInsight Capabilities

13. Disclaimer

14. About DelveInsight

List of Tables

Table 1: Summary of Fecal incontinence, Market, Epidemiology, and Key Events (2018–2030)

Table 2: Causes of Fecal Incontinence

Table 3: Classification of Fecal Incontinence

Table 4: Total Prevalent Patient Population of Fecal incontinence in 7MM (2018–2030)

Table 5: Prevalence of Fecal Incontinence in the United States (2018–2030)

Table 6: Prevalent Cases of Fecal Incontinence based on Risk Factors in the United States (2018–2030)

Table 7: Gender-specific Prevalence of Fecal Incontinence in the United States (2018–2030)

Table 8: Prevalence of Fecal Incontinence based on frequency in the United States (2018–2030)

Table 9: Prevalence of Fecal Incontinence in Germany (2018–2030)

Table 10: Prevalent Cases of Fecal Incontinence based on Risk Factors in Germany (2018–2030)

Table 11: Gender-specific Prevalence of Fecal incontinence in Germany (2018–2030)

Table 12: Prevalence of Fecal Incontinence based on frequency in Germany (2018–2030)

Table 13: Prevalence of Fecal Incontinence in France (2018–2030)

Table 14: Prevalent Cases of Fecal Incontinence based on Risk Factors in France (2018–2030)

Table 15: Gender-specific Prevalence of Fecal Incontinence in France (2018–2030)

Table 16: Prevalence of Fecal incontinence based on frequency in France (2018–2030)

Table 17: Prevalence of Fecal incontinence in Italy (2018–2030)

Table 18: Prevalent Cases of Fecal Incontinence based on Risk Factors in Italy (2018–2030)

Table 19: Gender-specific Prevalence of Fecal Incontinence in Italy (2018–2030)

Table 20: Prevalence of Fecal Incontinence based on frequency in Italy (2018–2030)

Table 21: Prevalence of Fecal Incontinence in Spain (2018–2030)

Table 22: Prevalent Cases of Fecal Incontinence based on Risk Factors in Spain (2018–2030)

Table 23: Gender-specific Prevalence of Fecal Incontinence in Spain (2018–2030)

Table 24: Prevalence of Fecal Incontinence based on frequency in Spain (2018–2030)

Table 25: Prevalence of Fecal Incontinence in United Kingdom (2018–2030)

Table 26: Prevalent Cases of Fecal Incontinence based on Risk Factors in United Kingdom (2018–2030)

Table 27: Gender-specific Prevalence of Fecal Incontinence in the United Kingdom (2018–2030)

Table 28: Prevalence of Fecal Incontinence based on frequency in the United Kingdom (2018–2030)

Table 29: Prevalence of Fecal Incontinence in Japan (2018–2030)

Table 30: Prevalent Cases of Fecal Incontinence based on Risk Factors in Japan (2018–2030)

Table 31: Gender-specific Prevalence of Fecal Incontinence in Japan (2018–2030)

Table 32: Prevalence of Fecal Incontinence based on frequency in Japan (2018–2030)

Table 33: Organizations contributing towards Fecal Incontinence (FI)

List of Figures

Figure 1: Sagittal view of the anorectal sphincter

Figure 2: Total Prevalent Population of Fecal incontinence in 7MM (2018–2030)

Figure 3: Prevalence of Fecal Incontinence in the United States (2018–2030)

Figure 4: Prevalent Cases of Fecal Incontinence based on Risk Factors in the United States (2018–2030)

Figure 5: Gender-specific Prevalence of Fecal Incontinence in the United States (2018–2030)

Figure 6: Prevalence of Fecal Incontinence based on frequency in the United States (2018–2030)

Figure 7: Prevalence of Fecal Incontinence in Germany (2018–2030)

Figure 8: Prevalent Cases of Fecal Incontinence based on Risk Factors in Germany (2018–2030)

Figure 9: Gender-specific Prevalence of Fecal Incontinence in Germany (2018–2030)

Figure 10: Prevalence of Fecal Incontinence based on frequency in Germany (2018–2030)

Figure 11: Prevalence of Fecal Incontinence in France (2018–2030)

Figure 12: Prevalent Cases of Fecal Incontinence based on Risk Factors in France (2018–2030)

Figure 13: Gender-specific Prevalence of Fecal Incontinence in France (2018–2030)

Figure 14: Prevalence of Fecal Incontinence based on frequency in France (2018–2030)

Figure 15: Prevalence of Fecal Incontinence in Italy (2018–2030)

Figure 16: Prevalent Cases of Fecal Incontinence based on Risk Factors in Italy (2018–2030)

Figure 17: Gender-specific Prevalence of Fecal Incontinence in Italy (2018–2030)

Figure 18: Prevalence of Fecal Incontinence based on frequency in Italy (2018–2030)

Figure 19: Prevalence of Fecal Incontinence in Spain (2018–2030)

Figure 20: Prevalent Cases of Fecal Incontinence based on Risk Factors in Spain (2018–2030)

Figure 21: Gender-specific Prevalence of Fecal Incontinence in Spain (2018–2030)

Figure 22: Prevalence of Fecal Incontinence based on frequency in Spain (2018–2030)

Figure 23: Prevalence of Fecal Incontinence in United Kingdom (2018–2030)

Figure 24: Prevalent Cases of Fecal Incontinence based on Risk Factors in United Kingdom (2018–2030)

Figure 25: Gender-specific Prevalence of Fecal Incontinence in the United Kingdom (2018–2030)

Figure 26: Prevalence of Fecal Incontinence based on frequency in the United Kingdom (2018–2030)

Figure 27: Prevalence of Fecal Incontinence in Japan (2018–2030)

Figure 28: Prevalent Cases of Fecal Incontinence based on Risk Factors in Japan (2018–2030)

Figure 29: Gender-specific Prevalence of Fecal Incontinence in Japan (2018–2030)

Figure 30: Prevalence of Fecal Incontinence based on frequency in Japan (2018–2030)

Forward to Friend

Need A Quote